Table 3.
RAASi prescription pattern among patients who survived 90 days after the index hyperkalemia episode
| RAASi | Total, N = 8145 | Received SPS/CPS prescription, N = 399 | No SPS/CPS prescription, N = 7746 | P-value |
|---|---|---|---|---|
| Discontinuation | 1447 (17.77%) | 71 (17.79%) | 1376 (17.76%) | 0.98 |
| Continuation | 6698 (82.23%) | 328 (82.21%) | 6370 (82.24%) | |
| Maximum dose | 1467 (18.01%) | 80 (20.05%) | 1387 (17.91%) | 0.53 |
| Submaximal dose | 5231 (64.22%) | 248 (62.16%) | 4983 (64.33%) |
Data are presented as n (%).